Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall OSTEOFIL DBM Paste, 5cc

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall OSTEOFIL DBM Paste, 5ccsee related information
Date Initiated by FirmApril 09, 2011
Date PostedJune 23, 2011
Recall Status1 Terminated 3 on July 24, 2012
Recall NumberZ-2634-2011
Recall Event ID 58887
510(K)NumberK043420 
Product Classification Filler,bone void, calcium compound - Product Code MQV
Product***Processed at: Regeneration TECHNOLOGIES, INC. Alachua, FL, USA 32615***Distributed by: SpinalGraft Technologies, LLC 4340 Swinnea Road STE 39 Memphis, TN 38118***OSTEOFIL DBM Paste, 5cc Tissue ID: 321933 Reorder: 002405 Lot #(Donor ID): 101050353 Expiration: 02/21/2013***STERILE***" Bone Void Filler used in spinal surgery.
Code Information 4179877, 4179878, 4179693, 4179694, 4179695, 4179696, 4179697, 4179698, 4179699, 4179870, 4179872, 4179873, 4179874, 4179875, 4179416, 4179417, 4179418, 4179419, 4179690, 3217933, 4179410, 4179411, 4179412, 4179413, 4179414.
Recalling Firm/
Manufacturer		 RTI Biologics, Inc.
11621 Research Cir
Alachua FL 32615-6825
For Additional Information ContactAudra McConnell
386-418-8888 Ext. 4806
Manufacturer Reason
for Recall		RTI Biologics issued a recall of Osteofil DBM Paste, 5cc that was distributed on 03/04/2008 to one customer. The product was labeled as 5.0cc but should have been labeled as 0.5cc. All customers were notified of this recall on 04/09/2011.
FDA Determined
Cause 2		Labeling mix-ups
ActionRTI Biologics sent a "VOLUNTARY RECALL" letter dated April 9, 2008 to the one distributor, Spinal Graft Technologies. LLC. The letter describes the product, problem, and action to be taken by the distributor. The letter states that some of the product was issued a return authorization and requests that the distributor recover the remaining product from distribution. The recovered product will be issued a return authorization. RTI states the grafts can be returned in a non frozen state. Recall effectiveness will be determined by return of the product.
Quantity in Commerce26 units
DistributionDomestic Distribution--TN only.
Total Product Life CycleTPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database510(K)s with Product Code = MQV
-
-